The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS
Abstract
Glial progenitor cells of the developing CNS committed to the oligodendrocyte lineage (OPCs) express the chondroitin sulfate proteoglycan, NG2. A proportion of OPCs fail to differentiate past the stage at which they express NG2 and the lipid antigen O4 and persist in the adult CNS in a phenotypically immature form. However, the physiological function of NG2(+) cells in the adult CNS is unknown. Using antibodies against NG2 we show that NG2 is expressed by a distinct cell population in the mature CNS with the homogeneous antigenic phenotype of oligodendrocyte progenitors. The morphology of NG2(+) OPCs varies from region to region, reflecting the different structural environments, but they appear to represent a homogeneous population within any one gray or white matter region. A study of nine CNS regions showed that NG2(+) OPCs are numerous throughout the CNS and numbers in the white matter are only 1.5 times that in the gray. Whereas the ratio of OPCs to myelinating oligodendrocytes in the spinal cord gray and white matter approximates 1:4, gray matter regions of the forebrain have a 1:1 ratio, a phenomenon that will have consequences for oligodendrocyte replacement following demyelination. BrdU incorporation experiments showed that NG2(+) cells are the major dividing cell population of the adult rat CNS. Since very little apoptosis was detected and BrdU became increasingly present in oligodendrocytes after a 10-day pulse chase, with a concomitant decrease in NG2(+) BrdU incorporating cells, we suggest that the size of the oligodendrocyte population may actually increase during adult life.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The adult mammalian CNS is known to harbor significant numbers of oligodendrocyte precursor cells in white matter”
From Preclinical biodistribution, tropism, and efficacy of oligotropic AAV/Olig001 in a mouse model of congenital white matter disease (2021) · cites this paper as [16]
Citations
Cites
Cell death and control of cell survival in the oligodendrocyte lineage
Barres, B. A., Hart, I. K., Coles, H. S. R., Burne, J. F., Voyvodic, J. T., Richardson, W. D., & Raff, M. C. (1992) · Cell · doi:10.1016/0092-8674(92)90531-g · Cited by 1,345
Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus
Bergles, D. E., Roberts, J. D. B., Somogyi, P., & Jahr, C. E. (2000) · Nature · doi:10.1038/35012083 · Cited by 1,062
Why does remyelination fail in multiple sclerosis?
Franklin, R. J. M. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn917 · Cited by 862
Proliferation and Differentiation of Progenitor Cells Throughout the Intact Adult Rat Spinal Cord
Horner, P. J., Power, A. E., Kempermann, G., Kuhn, H. G., Palmer, T. D., Winkler, J., Thal, L. J., & Gage, F. H. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-02218.2000 · Cited by 777
NG2-Positive Oligodendrocyte Progenitor Cells in Adult Human Brain and Multiple Sclerosis Lesions
Chang, A., Nishiyama, A., Peterson, J. W., Prineas, J. W., & Trapp, B. D. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06404.2000 · Cited by 711
The oligodendrocyte precursor cell in health and disease
Levine, J. M., Reynolds, R., & Fawcett, J. W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01691-x · Cited by 673
MYELINATION IN RAT BRAIN: CHANGES IN MYELIN COMPOSITION DURING BRAIN MATURATION1
Norton, W. T., & Poduslo, S. E. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb07520.x · Cited by 668
Sim, F. J., Zhao, C., Penderis, J., & Franklin, R. J. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02451.2002 · Cited by 625
Oligodendrocyte Population Dynamics and the Role of PDGF In Vivo
Calver, A. R., Hall, A. C., Yu, W., Walsh, F. S., Heath, J. K., Betsholtz, C., & Richardson, W. D. (1998) · Neuron · doi:10.1016/s0896-6273(00)80469-9 · Cited by 516
Pringle, N. P., & Richardson, W. D. (1993) · Development · doi:10.1242/dev.117.2.525 · Cited by 510
Cited by
Sorted by citations
Items 901–924 of 924
Mesaoudi, A. E. (2024) · theses.fr (ABES) · doi:10.70675/f339157ez1688z4acaz87fcz0ecae062a7cc
Pharmacogenomic identification of small molecules promoting oligodendrogenesis and myelin repair
Huré, J.-B. (2022) · theses.fr (ABES) · doi:10.70675/17691e80z7bacz455fzba89z49fef7be0512
Le mimétique de SMAC GDC-0152 : un nouvel immunomodulateur dans les glioblastomes
Snacel-Fazy, E. (2023) · theses.fr (ABES) · doi:10.70675/7e5e377fzaaa9z4f1dzbde6z9586007f6c3d
Rewiring the Glioma Ecosystem: Glial–Tumor Crosstalk, Immune Evasion, and Therapeutic Opportunities
Oukhdouch, A., Dref, M., Nadir, Y., Bouighajd, H., Marzouka, W. A., Elbah, I., Zinbi, B., Sellami, S., Hazmiri, F. E., & Rais, H. (2026) · Neuroglia · doi:10.3390/neuroglia7030025
Oligodendrocytes and lysosomal-autophagic networks: An emerging view
Jiménez-Ridruejo, I., & Plaza‐Zabala, A. (2026) · International review of cytology · doi:10.1016/bs.ircmb.2026.07.003
Sugimori, Y., Yano, Y., Asano, T., Suzuki, S., Kaigawa, T., Yokose, J., Shigetsura, Y., Muramatsu, S.-I., & Nitta, A. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111148
Harnessing Neurogenic Potential of Glial Cell Types as an Emerging Strategy for Treating Epilepsy
Chesnokova, E., Kotova, I., Reznikova, A., Balaban, P. M., & Bal, N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209147
Astrocyte-oligodendrocyte crosstalk dependent myelination via secreted protein YKL40Preprint
Dominguez, O., Munir, S., Thumu, S. C. R., Tuck, C., Gonzales, J. P. M., Oh, U., Kordula, T., Fuss, B., & Singh, S. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.08.750142
Oligodendrocytes in central nervous system health and disease
Ryan, L. J., & Miron, V. E. (2026) · Cell · doi:10.1016/j.cell.2026.08.003
Nakagawa, Y., & Yamada, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06217-9
Rethinking the Oligodendrocyte Progenitor Cell: One Cell, Many Functions
de la Fuente, A. G. (2026) · European Journal of Neuroscience · doi:10.1111/ejn.70676
Singh, R. K., Banerjee, C., & Mehan, S. (2026) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-026-10321-x
Baez, C. B.-R., Xin, X., Lyu, H., Kirianov, D., Sun, Y., Späte, E., Grassia, M., Engeland, B., Stockebrand, M. C., Khodosevich, K., et al. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02437-1
LightSuite: scalable atlas registration and cell detection across the central nervous systemPreprint
Karamanlis, D., Xie, Y., Foucher, C. G., Alappat, M., Masood, A., Dimitropoulou, I., Pivron, L. A. F., de Paz, J. M. M., Macé, É., Gaspari, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.13.757638
The role of beta1 integrin in myelination and remyelination
Lee, K. K. C. (2009) · uO Research (University of Ottawa) · doi:10.20381/ruor-19952
Electrical responses of oligodendrocytes to pathological stimuli
Kołodziejczyk, K. (2011) · UCL Discovery (University College London)
Glial Control of Synapse Assembly at the Drosophila Neuromuscular Junction: A Dissertation
Kerr, K. S. (2012) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/7wgw-yc32
Poli, A. (2013) · NORA - Norwegian Open Research Archives
Regenerative Potential of NG2 Cells
Mangin, J. (2014) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4899-7399-3_7
Metadata
- Authors
- Dawson, M.
- Affiliations
- Charing Cross Hospital (GB)
- Corresponding author
- Dawson, M
- Venue
- Molecular and Cellular Neuroscience
- Publisher
- Elsevier BV
- Published
- 2003-10
- Volume
- 24
- Issue
- 2
- Pages
- 476-488
- ISSN
- 1044-7431 (ISSN-L)
- OpenAlex
- W1985286185
- Cited by
- 927
- References
- 43
- Citations by year
- 2026: 25 · 2025: 27 · 2024: 56 · 2023: 54 · 2022: 38 · 2021: 71 · 2020: 57 · 2019: 46 · 2018: 51 · 2017: 59 · 2016: 40 · 2015: 48 · 2014: 43 · 2013: 52 · 2012: 28
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular and Cellular Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- NG2, oligodendrocyte precursor cells, cell cycling, oligodendrocyte lineage, myelination, demyelination, white matter, gray matter, BrdU incorporation, apoptosis, O4, chondroitin sulfate proteoglycans
- MeSH terms
- Chondroitin Sulfate Proteoglycan 4, Animals, Antigens, Cell Cycle, Central Nervous System, Gene Expression Regulation, Male, Neuroglia, Proteoglycans, Stem Cells, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
